María Elena Cardoso, Paula Decuadra, Maia Zeni, Agustín Delfino, Emilia Tejería, Fátima Coppe, Juan Manuel Mesa, Grysette Daher, Javier Giglio, Gonzalo Carrau, Daniela Gamenara, Omar Alonso, Mariella Terán, Ana Rey
With the objective to develop a potential 99m Tc radiopharmaceutical for imaging the androgen receptor (AR) in prostate cancer, four ligands bearing the same pharmacophore derived from the AR antagonist flutamide were prepared, labeled with 99m Tc, and their structures corroborated via comparison with the corresponding stable rhenium analogs. All complexes were obtained with high radiochemical purity. Three of the complexes were highly stable, and, due to their favorable physicochemical properties, were further evaluated using AR-positive and AR-negative cells in culture...
January 13, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry